Cargando…

Expression and clinical significance of RBBP4 gene in lower-grade glioma: An integrative analysis

This study investigated the expression pattern of retinoblastoma binding protein 4 (RBBP4) gene in glioma and explored its associations with clinicopathologic characteristics and prognosis of patients. Data retrieved from the GEPIA, CGGA, HPA and TIMER databases were processed to analyze RBBP4 expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Ruofei, Xiang, Yue, Hu, Chao, Tang, Xiaoping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10469049/ https://www.ncbi.nlm.nih.gov/pubmed/37664524 http://dx.doi.org/10.1016/j.bbrep.2023.101533

Ejemplares similares

The Significance of IDH1 Mutations in Tumor-Associated Seizure in 60 Chinese Patients with Low-Grade Gliomas
por: Liang, Ruofei, et al.
Publicado: (2013)

Hypoxia-induced RBBP7 promotes esophagus cancer progression by inducing CDK4 expression: RBBP7 promotes esophagus cancer progression
por: Wang, Renfeng, et al.
Publicado: (2022)

Prognostic significance of epidermal growth factor receptor expression in glioma patients
por: Li, Junhong, et al.
Publicado: (2018)

Prognosis value of RBBP8 expression in plasma cell myeloma
por: Zhang, Weilong, et al.
Publicado: (2019)

Prognostic significance of age related genes in patients with lower grade glioma
por: Wang, Haiwei, et al.
Publicado: (2020)

Rbbp4 Suppresses Premature Differentiation of Embryonic Stem Cells
por: Huang, Yikai, et al.
Publicado: (2021)

RBBP4 Enhances Platinum Chemo Resistance in Lung Adenocarcinoma
por: Wang, Nianwu, et al.
Publicado: (2021)

Integrated Multi-Omics Maps of Lower-Grade Gliomas
por: Binder, Hans, et al.
Publicado: (2022)

Characterization and prognostic significance of alternative splicing events in lower‐grade diffuse gliomas
por: Zhao, Zheng, et al.
Publicado: (2020)

Lower Grade Gliomas
por: Youssef, Gilbert, et al.
Publicado: (2020)

Prognostic value of CtIP/RBBP8 expression in breast cancer
por: Soria-Bretones, Isabel, et al.
Publicado: (2013)

Investigating the Effects of RBBP6 Gene Expression on Telomerase Activity in Cervical Cancer Cells
por: Mosweu, Mpho, et al.
Publicado: (2020)

Preclinical modeling of lower-grade gliomas
por: Tang, Lilly W., et al.
Publicado: (2023)

Classifying lower grade glioma cases according to whole genome gene expression
por: Chen, Baoshi, et al.
Publicado: (2016)

Comprehensive analysis of the clinical and biological significances of cholesterol metabolism in lower-grade gliomas
por: Tao, Rui, et al.
Publicado: (2023)

Classification of diffuse lower‐grade glioma based on immunological profiling
por: Wu, Fan, et al.
Publicado: (2020)

RBBP4 dysfunction reshapes the genomic landscape of H3K27 methylation and acetylation and disrupts gene expression
por: Mu, Weipeng, et al.
Publicado: (2022)

Clinical significance of FBXO17 gene expression in high-grade glioma
por: Du, Di, et al.
Publicado: (2018)

Protocol for integrative subtyping of lower-grade gliomas using the SUMO pipeline
por: Sienkiewicz, Karolina, et al.
Publicado: (2022)

NI-09 CLINICAL SIGNIFICANCE OF T2-FLAIR MISMATCH SIGN IN LOWER GRADE GLIOMAS
por: Deguchi, Shoichi, et al.
Publicado: (2019)

Resilience in Lower Grade Glioma Patients
por: Fröhlich, Ellen, et al.
Publicado: (2022)

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma
por: Zhang, Mingwei, et al.
Publicado: (2020)

Integrated Analysis Reveals Prognostic Value and Immune Correlates of CD86 Expression in Lower Grade Glioma
por: Qiu, Huaide, et al.
Publicado: (2021)

Identification of EMT-Related Genes and Prognostic Signature With Significant Implications on Biological Properties and Oncology Treatment of Lower Grade Gliomas
por: Wu, Jiasheng, et al.
Publicado: (2022)

Unveiling the molecular structure and role of RBBP4/7: implications for epigenetic regulation and cancer research
por: Cai, Lize, et al.
Publicado: (2023)

Correlation Between APOBEC3B Expression and Clinical Characterization in Lower-Grade Gliomas
por: Zhang, Hao, et al.
Publicado: (2021)

RBBP6 Is Abundantly Expressed in Human Cervical Carcinoma and May Be Implicated in Its Malignant Progression
por: Dlamini, Zodwa, et al.
Publicado: (2019)

ADAM9 Expression Is Associate with Glioma Tumor Grade and Histological Type, and Acts as a Prognostic Factor in Lower-Grade Gliomas
por: Fan, Xing, et al.
Publicado: (2016)

Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma
por: Zhang, Mingwei, et al.
Publicado: (2020)

The internal interaction in RBBP5 regulates assembly and activity of MLL1 methyltransferase complex
por: Han, Jianming, et al.
Publicado: (2019)

Identification and validation of a three-gene signature as a candidate prognostic biomarker for lower grade glioma
por: Xiao, Kai, et al.
Publicado: (2020)

PLEKHA4 is a novel prognostic biomarker that reshapes the tumor microenvironment in lower-grade glioma
por: Zhi, Wenqian, et al.
Publicado: (2023)

Identifying RBBP7 as a Promising Diagnostic Biomarker for BK Virus-Associated Nephropathy
por: Wang, Yicun, et al.
Publicado: (2022)

RBBP4 is an epigenetic barrier for the induced transition of pluripotent stem cells into totipotent 2C-like cells
por: Ping, Wangfang, et al.
Publicado: (2023)

The integrative analysis based on super-enhancer related genes for predicting different subtypes and prognosis of patient with lower-grade glioma
por: Hu, Yungang, et al.
Publicado: (2023)

An Immune-Related Signature for Predicting the Prognosis of Lower-Grade Gliomas
por: Zhang, Hongbo, et al.
Publicado: (2020)

RBBP6 induces non-small cell lung cancer cell proliferation and high expression is associated with poor prognosis
por: Wang, Qiu-Shi, et al.
Publicado: (2020)

Multicellular “hotspots” harbor high-grade potential in lower-grade gliomas
por: Kirby, Alastair J, et al.
Publicado: (2021)

Identification of a novel cuproptosis-related gene signature and integrative analyses in patients with lower-grade gliomas
por: Bao, Jia-hao, et al.
Publicado: (2022)

Clusterin Is a Prognostic Biomarker of Lower-Grade Gliomas and Is Associated with Immune Cell Infiltration
por: Ren, Xiaoyue, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n2aar9ftanrpnbqert7nfag1hq